These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12036535)

  • 41. MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.
    Noiri E; Taguchi J; Nakao A; Fujita T
    Diabetes Care; 2000 Feb; 23(2):260. PubMed ID: 10868846
    [No Abstract]   [Full Text] [Related]  

  • 42. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk.
    Lievers KJ; Boers GH; Verhoef P; den Heijer M; Kluijtmans LA; van der Put NM; Trijbels FJ; Blom HJ
    J Mol Med (Berl); 2001 Sep; 79(9):522-8. PubMed ID: 11692165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.
    Song C; Xing D; Tan W; Wei Q; Lin D
    Cancer Res; 2001 Apr; 61(8):3272-5. PubMed ID: 11309278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implications on human fertility of the 677C-->T and 1298A-->C polymorphisms of the MTHFR gene: consequences of a possible genetic selection.
    Reyes-Engel A; Muñoz E; Gaitan MJ; Fabre E; Gallo M; Dieguez JL; Ruiz M; Morell M
    Mol Hum Reprod; 2002 Oct; 8(10):952-7. PubMed ID: 12356947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous detection of methylenetetrahydrofolate reductase gene polymorphisms, C677T and A1298C, by melting curve analysis with LightCycler.
    Nakamura S; Aoshima T; Ikeda M; Sekido Y; Shimokata K; Niwa T
    Anal Biochem; 2002 Jul; 306(2):340-3. PubMed ID: 12123675
    [No Abstract]   [Full Text] [Related]  

  • 47. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM.
    Arai K; Yamasaki Y; Kajimoto Y; Watada H; Umayahara Y; Kodama M; Sakamoto K; Hori M
    Diabetes; 1997 Dec; 46(12):2102-4. PubMed ID: 9392503
    [No Abstract]   [Full Text] [Related]  

  • 48. Absence of association of fetal MTHFR C677T polymorphism with prenatal Down syndrome pregnancies.
    Yanamandra K; Bocchini JA; Thurmon TF
    Eur J Hum Genet; 2003 Jan; 11(1):5. PubMed ID: 12529699
    [No Abstract]   [Full Text] [Related]  

  • 49. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women.
    Kaiser T; Brennecke SP; Moses EK
    Gynecol Obstet Invest; 2000; 50(2):100-2. PubMed ID: 10965192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The MTHFR C677T, APOE, and PON55 gene polymorphisms show relevant interactions with cardiovascular risk factors.
    Murphy MM; Vilella E; Ceruelo S; Figuera L; Sanchez M; Camps J; Cuco G; Ferré N; Labad A; Tasevska N; Arija V; Joven J; Fernandez-Ballart J
    Clin Chem; 2002 Feb; 48(2):372-5. PubMed ID: 11805025
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of an internal restriction control in the PCR detection of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation.
    Lastrucci RM; Dawson DA; Münster M
    Mol Diagn; 1999 Jun; 4(2):159-61. PubMed ID: 10462631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients.
    Neugebauer S; Baba T; Watanabe T
    Lancet; 1998 Aug; 352(9126):454. PubMed ID: 9708759
    [No Abstract]   [Full Text] [Related]  

  • 53. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
    Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylene tetrahydrofolate reductase gene and coronary artery disease.
    Iqbal MP; Frossard PM
    J Pak Med Assoc; 2003 Jan; 53(1):33-6. PubMed ID: 12666851
    [No Abstract]   [Full Text] [Related]  

  • 55. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
    Brown CA; McKinney KQ; Young KB; Norton HJ
    Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.
    Sohda S; Arinami T; Hamada H; Yamada N; Hamaguchi H; Kubo T
    J Med Genet; 1997 Jun; 34(6):525-6. PubMed ID: 9192280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.
    González-Fraile MI; García-Sanz R; Mateos MV; Balanzategui A; González M; Váquez L; San Miguel JF
    Br J Haematol; 2002 Jun; 117(4):890-2. PubMed ID: 12060127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
    Fukasawa M; Matsushita K; Kamiyama M; Mikami Y; Araki I; Yamagata Z; Takeda M
    Am J Kidney Dis; 2003 Mar; 41(3):637-42. PubMed ID: 12612987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T.
    Linnebank M; Homberger A; Nowak-Göttl U; Marquardt T; Harms E; Koch HG
    Eur J Pediatr; 2000 Jun; 159(6):472-3. PubMed ID: 10867857
    [No Abstract]   [Full Text] [Related]  

  • 60. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
    Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
    Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.